ABCL AbCellera Biologics Inc. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
16:12
Oct 14
wliang
ABCL ready for next leg up
Sees ABCL holding proper levels and ready for the next leg up; earlier said he remains bullish on the biotech theme for Q4 and ABCL should do well.
ABCL AbCellera Biologics Inc. Long — —
15:27
Oct 13
wliang
Bullish Q4 biotech theme includes ABCL
Remains bullish on the entire biotech theme for Q4 and says ABCL should do well.
ABCL AbCellera Biologics Inc. Long — —
17:09
Oct 12
wliang
ABCL strength expected in Q4
Expects Q4 biotech strength and sees ABCL strengthening throughout Q4 as one of several named biotech names.
ABCL AbCellera Biologics Inc. Long 1ST — —
Log in to see ideas

About ABCL Investor Commentary

Across the available history and selected sources, Buzzberg tracks ABCL (AbCellera Biologics Inc.) across 19 sources: 36 bullish vs 5 bearish calls from 22 authors. Historical directional balance: 27% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 116 total trade ideas tracked. Past 7 days, before deduplication: 1 other directions. Latest voices: wliang.